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Abstract
Background: Cigarette smoking is an established causal factor for atherosclerosis. However, the
smoking effect on different echogenic components of carotid arterial wall measured by ultrasound
is not well elucidated.
Methods: Middle-aged men and women who had IMT measurement ≥ 0.7 mm at baseline and
follow-up were included (N = 413, age 40–60 years at baseline in 1995). Intima-media thickness of
common carotid artery (CCA-IMT) and its components (echogenic and echolucent layers) were
measured at baseline and in the follow-up examination 3 years later. IMT and its components were
compared across current, former and never smokers. Individual growth models were used to
examine how smoking status was related to the baseline and progression of overall IMT and IMT
components.
Results: For both men and women, current smoking was associated with thicker echogenic layer
than never smokers; former smokers exhibited thinner echogenic layer than current smokers after
adjustment for cigarette pack-years. Among women, current smoking was also associated with a
thinned echolucent layer that resulted in a non-significant overall association of current smoking
with IMT for women.
Conclusion: Cigarette smoking is associated with carotid artery morphological changes and the
association is sex-dependent. The atherogenic effect of smoking appears to be partly reversible
among former smokers. IMT measurement alone may not be adequate to detect carotid
atherosclerosis associated with cigarette smoking among middle-age women.
Background
Cigarette smoking is a causative factor for premature
atherosclerosis [1,2]. However, the exact mechanism of
smoking-induced damage to the arterial wall and its rela-
tion to the atherosclerotic process is still largely obscure.
The adverse effects of smoking on vascular wall structure
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has been historically evaluated by autopsy studies [3].
Clinically applicable diagnostic measurements such as
ultrasound imaging are widely utilized in recent years
[4,5].
The B-mode ultrasonographic image for a normal carotid
artery is characterized by two parallel echogenic lines sep-
arated by an echolucent (hypoechoic) space. The parallel
echoes correspond to the adventitial and intimal layers of
the arterial wall, and the intervening echolucent region
represents the media [6], although there may be system-
atic discrepancies between sonographic and histological
measurements of intimal and medial thickness [7,8].
Prior reports have been mixed regarding the relations
between cigarette smoking and ultrasound-measured
carotid intima-medial thickness (IMT). Whereas some
researchers reported no significant differences in IMT of
the common carotid artery (CCA) or differences in pro-
gression of IMT between smokers and nonsmokers [9,10],
others reported greater CCA-IMT in smokers [11-13], and
that smoking is associated with echogenic plaques [14]. In
addition, it is suggested that some harmful effects of
smoking on the vessel wall are sex-related [14-16]. How-
ever, no study has been performed to determine specifi-
cally the association between cigarette smoking and
carotid morphological changes in terms of arterial wall
components detected by ultrasonography and whether
there are any sex differences on those effects.
Changes in arterial wall thickness indicate structural arte-
rial changes resulting from arterial remodeling, most
often due to the atherosclerotic process. CCA-IMT is con-
ventionally used as a marker of subclinical atherosclerosis
[17], although important limitations of this marker have
been recognized [18]. The aim of this study was to evalu-
ate the chronic association between cigarette smoking on
carotid IMT and IMT components. The following hypoth-
eses were tested among middle-age adults: (1) smoking-
related carotid artery wall changes involve both intimal
and medial thickness; (2) the smoking-related alteration
in carotid arterial wall is partly reversible upon smoking
cessation in former smokers; and (3) there are sex differ-
ences among these relations.
Methods
Subjects
The Los Angeles Atherosclerosis Study (LAAS) cohort was
recruited from a local utility company with over-sampling
of smokers and persons of Hispanic origin. The cohort (n
= 573) consists of women (age 45–60 yr) and men (age
40–60 yr) who had no history of coronary heart disease
(CHD), stroke or cancer at baseline. The baseline exami-
nation (Exam 1) was completed in 1995. Two follow-up
examinations were completed at 1.5-yr intervals. A sub-
cohort was derived from the initial cohort who had IMT
measurement greater or equal to 0.7 mm at baseline
(Exam 1) and 3-yr follow-up (Exam 3). A total of 413 sub-
jects (men, n = 231; women, n = 182) met this criteria and
were included to have IMT components (echogenic and
echolucent layer) measured at Exam 1 and Exam 3 in
addition to overall IMT. Written informed consent was
obtained from all participants and the study protocol was
approved by the Institutional Review Board of the Keck
School of Medicine at the University of Southern Califor-
nia.
Outcome measurement
Procedures for image acquisition and processing have
been previously reported [19]. In brief, arterial images
were acquired with a portable B-mode ultrasound scanner
(ATL scanner, model UM4+, with 7.5 MHz linear-array
transducer). Continuous B-mode images and simultane-
ous 3-lead electrocardiograms were recorded on super-
VHS videotape. Videotapes were then processed using the
automatic edge-tracking software called Prosound [20].
IMT was measured at the far wall of the artery in the 1 cm
section of the common carotid 0.25 cm proximal to the
bulb. The subjects were scanned in two body positions
(supine and lateral) and on two sides (right and left). Up
to 8 frames were processed for each subject. The same
ultrasound images that were processed to obtain the IMT
measurements were retrieved to obtain echogenic and
echolucent layer thickness. The echogenic layer was meas-
ured manually (versus automated edge detection used for
IMT measurement) by measuring the echogenic layer
along the same 1 cm portion of the CCA used for IMT
measurement. The echolucent layer was calculated as the
difference between the IMT measurement and the echo-
genic measurement. The intra-observer coefficient of vari-
ation (CV) for IMT is 4.2% and is 14.4% for echogenic
layer thickness measurement. The IMT protocol in LAAS
reduces reproducibility error by more than 50% relative to
several protocols used in other major studies [19]. A single
sonographer and a single ultrasound image analyst were
used throughout the study to avoid inter-observer varia-
tion. The IMT progression was determined by the differ-
ence between baseline and 3-yr follow-up after
adjustment for the time between the two examinations. In
addition to overall CCA-IMT, two echographic compo-
nents of the IMT (the echogenic layer and the echolucent
layer) were also measured for those with IMT measure-
ment ≥ 0.7 mm. This criterion was adopted because of the
difficulty in obtaining accurate thickness measurements
for IMT components (echolucent and echogenic) if over-
all IMT is less than 0.7 mm.
Exposure measurement
Smoking status was defined by self-report as former, cur-
rent, and never smokers. Former smokers were smokersBMC Cardiovascular Disorders 2006, 6:42 http://www.biomedcentral.com/1471-2261/6/42
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who had ceased smoking prior to the baseline examina-
tion and remained abstinent during the 3-year follow-up.
The cumulative cigarette exposure (i.e., smoking pack-
years) was estimated from self-reports of cigarette smok-
ing from the baseline questionnaire. Cumulative exposure
was calculated as packs smoked daily multiplied by the
number of years smoked. Cumulative cigarette pack-yrs
were categorized separately by sex into 4 groups (0–3).
Zero indicates never smokers; groups 1 to 3 were deter-
mined by sex-specific tertiles of smoking pack-years.
Statistical analysis
In the evaluation of current smoking-IMT relationship,
former smokers were excluded to avoid confounding by
smoking cessation; in the evaluation of the effects of
smoking cessation, never smokers were excluded and cig-
arette pack-years were controlled for former and current
smokers; in the evaluation of former smoking effects, cur-
rent smokers were excluded. These approaches were
applied to avoid colinearity between smoking variables
and separate effects of current and former smoking dis-
tinctly [21]. A significance level of α = 0.017 (approxi-
mately 0.05/3) for each separate test is used to guarantee
an overall significance level of no more than 0.05 (Bonfer-
roni correction).
Individual growth models (PROC MIXED in SAS) were
used to examine the effects of cigarette smoking and
smoking cessation on the baseline and progression of IMT
and IMT components [22,23]. Initial level of IMT (and
components) and time to examination (0, 1.5 or 3 yr)
were specified as random effects, and initial levels and
progression rates were allowed to co-vary. The between-
examination covariance matrix of the individual level
residuals was unconstrained. Covariate-adjusted least
square means for baseline and progression of IMT across
smoking pack-year categories were estimated at sex-spe-
cific means of covariates. Cross-sectional associations
between smoking and baseline IMT were estimated as
main effects, while associations between smoking and
IMT progression were estimated as interactions between
factors and time of examination. Parameter estimates
were obtained by maximum likelihood estimation meth-
ods. Tests for linear or curvilinear trend were based on
ordinal categories (0–3) of smoking pack-years. All analy-
ses were completed using SAS (version 8.2, SAS Institute
Inc., Cary, NC).
There were significant interactions of smoking variables
with sex as predictors of IMT and IMT components (p <
0.01). Thus the multivariate analyses were performed for
men and women separately.
Results
Smoking was more prevalent among the subjects included
in this analysis compared with excluded subjects, espe-
cially among men (32.9% vs. 19.2% in men, p = 0.03;
21.4% vs. 16.1% in women, p  = 0.30). A comparison
between included and non-included subjects on major
cardiovascular risk factors at baseline indicated that the
included subjects had significantly higher levels of LDL
cholesterol, blood pressure, BMI, ratio of sagittal to trans-
verse abdominal diameter (an indicator abdominal obes-
ity), and lower levels of HDL even after adjustment for
sex, age, and smoking status (Table 1). Compared to
women, men exhibited significantly greater IMT, echo-
genic layer thickness, and proportion of echogenic layer
thickness at baseline (Table 2). There was no appreciable
sex difference for the absolute value of echolucent layer
thickness, although the proportion of echolucent layer
thickness was smaller in men than in women (p < 0.01).
Thus, the sex difference for echogenic layer thickness
essentially accounted for the sex difference in overall IMT.
Current smoking association with overall IMT and IMT 
components (i.e., current vs. never smokers)
Among women, current smokers exhibited thicker echo-
genic (p = 0.001) but thinner echolucent layers compared
to never smokers (p = 0.03). Because of these two oppo-
site effects, there was no association between current
smoking and overall IMT in women (p = 0.54). The over-
all effect of current smoking on progression of IMT was
Table 1: Comparison of major cardiovascular risk factors between included and excluded subjects *
Baseline variables Included (n = 413) Non-included (n = 160) p
BMI (kg/m2) 28.5 ± 0.3b 26.2 ± 0.4 <0.0001
Rsag2Tr 0.67 ± 0.003 0.65 ± 0.004 0.002
LDL cholesterol (mmol/L) 3.53 ± 0.05 3.30 ± 0.07 0.009
HDL cholesterol (mmol/L) 1.44 ± 0.01 1.55 ± 0.02 0.0001
SBP (mmHg) 130 ± 0.7 124 ± 1.1 <0.0001
DBP (mmHg) 91. ± 0.5 88 ± 0.7 0.0004
* Values are least square mean ± standard error. The parameter estimates were obtained from general linear modeling procedure with adjustment 
for sex, age, and smoking status (current, former, and never). BMI, body mass index. RSag2Tr, ratio of sagittal to transverse abdominal diameter. 
Trig, triglycerides. LDL-C, low-density lipoprotein cholesterol. HDL-C, high-density lipoprotein cholesterol. SBP, systolic blood pressure. DBP, 
diastolic blood pressure.BMC Cardiovascular Disorders 2006, 6:42 http://www.biomedcentral.com/1471-2261/6/42
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not significant among women (p = 0.38). Among men,
current smokers had a thicker echogenic layer (p = 0.01)
and thicker overall IMT (p < 0.001) compared to never
smokers. Contrary to women, there were no significant
effects of current smoking on the echolucent layer in men.
There were no significant associations between current
smoking and progression of IMT, and echogenic and
echolucent layer thickness among men (Table 3).
Smoking cessation relations (i.e., former vs. current 
smokers)
After controlling for age, body height, ethnicity, and ciga-
rette pack-years, significantly smaller echogenic-layer
thickness (p = 0.01) was evident for former female smok-
ers in comparison with current female smokers. There was
no significant association between overall IMT and smok-
ing cessation in women. In men, former smokers mani-
fested a thinner overall IMT (p = 0.01) compared with
current smokers (Table 4).
Past smoking relations with overall IMT and IMT 
components (i.e., former vs. never smokers)
Former female smokers evidenced more rapid progression
of overall IMT (p = 0.006) and echogenic layer thickness
(p = 0.0004) than never smokers. Former male smokers
manifested increased progression (p < 0.0001) of overall









Women (N = 132)
Intima-medial 
thickness(µm)
679.7 ± 14.5 668.3 ± 10.6 11.3 ± 18.4 0.54 13.6 ± 3.1 10.3 ± 2.0 3.2 ± 3.7 0.38
Echogenic layer (µm) 375.0 ± 14.1 315.1 ± 10.3 59.9 ± 17.8 0.001 -4.7 ± 4.4 7.7 ± 3.0 -12.4 ± 5.3 0.02
Echolucent layer (µm) 316.0 ± 16.6 360.9 ± 12.1 -44.8 ± 20.9 0.03 0.6 ± 3.3 11.2 ± 5.2 -10.6 ± 6.1 0.09
Men (N = 164)
Intima-medial 
thickness(µm)
743.8 ± 11.1 680.0 ± 10.3 63.8 ± 15.9 <.0001 15.1 ± 2.3 11.1 ± 2.0 4.0 ± 3.2 0.22
Echogenic layer (µm) 389.3 ± 13.2 340.9 ± 12.8 48.4 ± 19.4 0.01 6.5 ± 4.0 8.3 ± 3.8 -1.8 ± 5.8 0.76
Echolucent layer (µm) 360.3 ± 11.2 346.2 ± 11.0 14.1 ± 16.6 0.40 8.3 ± 4.4 -0.2 ± 4.1 8.5 ± 6.3 0.18
*Data are presented as least-square mean ± standard error. The parameter estimates were obtained from individual growth models, adjusted for 
age, body height, and race/ethnicity.
Table 2: Baseline characteristics of the study subjects (N = 413)
Variables Men (n = 231) Women (n = 182) p for differencea
No. (%) of subjects
Ethnicity .12
Hispanic 65 (38.1) 48 (26.4)
Non-Hispanic white 135 (58.5) 99 (54.4)
Black 11 (4.8) 15 (8.2)
Asian 10 (4.3) 18 (9.9)
Other 10 (4.3) 2 (1.1)
Smoking status .005
Current smokers 76 (32.9) 39 (21.4)
Former smokers 67 (29.0) 50 (27.4)
Never smokers 88 (38.1) 93 (51.2)
Mean ± SD
Age (yr) 49.3 ± 4.5 51.9 ± 4.5 <.0001
Body height (m) 1.76 ± .07 1.61 ± .07 <.0001
Body mass index (kg/m2) 29.0 ± 4.9 28.0 ± 6.3 .002
Mean IMTb(µm) 708.8 ± 96.3 682.1 ± 88.0 <.0001
Echogenic layer 364.4 ± 98.1 331.0 ± 67.8 <0.0001
Echogenic layer (% IMT) 44.5 ± 7.4 42.6 ± 7.1 0.0093
Echolucent layer 362.9 ± 83.9 367.9 ± 91.5 0.78
Echolucent layer (% IMT) 50.0 ± 9.3 52.3 ± 9.4 0.01
a p values for categorical variables were based on x2 analysis; p values for continuous variables were based on ANOVA.
b IMT, carotid artery intima-media thicknessBMC Cardiovascular Disorders 2006, 6:42 http://www.biomedcentral.com/1471-2261/6/42
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IMT compared to never smokers. There was no apprecia-
ble echolucent-layer difference in progression between
former and never smokers for both men and women
(Table 5).
Discussion
Prior study has demonstrated that smoking has a specific
fibrogenic effect which causes intimal thickening [24].
Autopsy studies have provided strong evidence for the
effects of smoking on aortic [25] and coronary atheroscle-
rosis [26]. Furthermore, the degree of atherosclerosis cor-
relates with the intensity of smoking (both with the
average number of cigarettes smoked per day and the
duration of smoking) [14]. These findings are also consist-
ent with the evidence that cigarette smoking and duration
of smoking are positively associated with markers of
inflammation [27], which may be one of many mecha-
nisms of intimal injury from smokers.
Pre-clinical atherosclerosis is thought to be mainly an inti-
mal atherosclerotic process [28]; However, the manner in
which the media changes during the progression of
atherosclerosis is still unclear. Some researchers have sug-
gested that media hypertrophy accompanies atherosclero-
sis progression [29-31], while others have suggested that
there is a moderate attenuation of the media [32], or that
the media is unaffected in type I to III lesions, but may be
modified in very advanced stages of atherosclerosis [28].
Adding more complexity, there is an argument that IMT is
not an ideal indicator for early atherosclerosis because it
consists mainly of media. The current study provides evi-
dence that the medial layer (most likely corresponding to
echolucent layer) may not necessarily get thickened dur-
ing the smoking-related atherosclerotic process, which
may partially explain poor correlation of IMT with clinical
endpoints such as coronary disease in some studies
[18,33].














Women (N = 143)
Intima-medial 
thickness(µm)
678.4 ± 13.4 672.9 ± 10.8 5.5 ± 16.2 0.74 10.0 ± 2.8 10.2 ± 2.1 -0.2 ± 3.3 0.94
Echogenic layer (µm) 314.6 ± 8.3 317.6 ± 6.8 -3.0 ± 10.1 0.76 13.6 ± 3.3 7.0 ± 2.6 6.5 ± 4.0 0.10
Echolucent layer (µm) 367.4 ± 14.6 361.3 ± 11.8 6.1 ± 17.7 0.73 -3.5 ± 3.8 1.7 ± 2.9 -5.2 ± 4.5 0.24
Men (N = 155)
Intima-medial 
thickness(µm)
707.9 ± 9.7 677.2 ± 9.2 30.7 ± 13.3 0.02 11.6 ± 2.2 12.0 ± 2.0 0.4 ± 3.0 0.89
Echogenic layer (µm) 341.8 ± 9.0 341.7 ± 8.6 0.08 ± 12.4 0.99 7.9 ± 3.5 6.8 ± 3.3 1.1 ± 4.8 0.82
Echolucent layer (µm) 372.5 ± 10.6 344.8 ± 10.2 27.7 ± 14.7 0.06 1.1 ± 3.7 1.7 ± 3.5 0.60 ± 5.1 0.90
* Data are presented as least-square mean ± standard error. The parameter estimates were obtained from individual growth models, adjusted 
for age, body height, and race/ethnicity.












Women (N = 89)
Intima-medial thickness(µm) 685.8 ± 38.4 687.2 ± 29.0 -1.4 ± 24.3 0.95 6.8 ± 8.9 4.9 ± 7.1 1.9 ± 5.4 0.72
Echogenic layer (µm) 360.3 ± 34.6 301.6 ± 26.0 58.6 ± 22.2 0.01 1.6 ± 13.3 20.1 ± 10.3 -18.5 ± 8.4 0.03
Echolucent layer (µm) 341.6 ± 38.9 391.6 ± 29.2 -50.1 ± 24.9 0.048 -6.1 ± 12.2 -18.4 ± 9.4 12.3 ± 7.8 0.12
Men (N = 143)
Intima-medial thickness(µm) 764.4 ± 33.3 718.2 ± 26.1 46.2 ± 18.6 0.01 10.0 ± 7.1 9.2 ± 5.6 0.8 ± 4.1 0.84
Echogenic layer (µm) 356.7 ± 37.3 314.4 ± 29.9 42.3 ± 21.1 0.047 16.9 ± 9.1 16.8 ± 7.5 0.1 ± 5.4 0.98
Echolucent layer (µm) 406.9 ± 27.8 404.3 ± 22.5 2.6 ± 15.8 0.87 -6.7 ± 10.8 -9.5 ± 8.8 2.8 ± 6.3 0.66
* Data are presented as least-square mean ± standard error. The parameter estimates were obtained from individual growth models among 
smokers, adjusted for age, body height, race/ethnicity, and cigarette pack-yrs.BMC Cardiovascular Disorders 2006, 6:42 http://www.biomedcentral.com/1471-2261/6/42
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The current study reveals that current cigarette smoking
correlated to a thinner echolucent layer in women. This
effect (p = .03) does not reach statistical significance if
Bonferroni correction is considered. However, the oppo-
site effects of smoking effects on two IMT components
(thickening of echogenic layer and thinning of echolucent
layer) resulted in null association between current smok-
ing and overall IMT in women (p = 0.54). Why thinning
echolucent layer occurs particularly among female smok-
ers is not clear, but there may be three putative mecha-
nisms underlying this pathological phenomenon. First,
because the matrix macromolecules of the media are pro-
duced by smooth muscle cells (SMC), the thinned echolu-
cent layer could be caused by media stretching without a
compensatory increase in matrix protein synthesis. Sec-
ond, the thinned echolucent layer may be caused by
smoking-induced SMC apoptosis [34] and consequent
medial atrophy. There was indirect supporting evidence
that smoking is related to decreased arterial smooth mus-
cle mass. For example, smoking is an important risk factor
for the development of abdominal aortic aneurysms
(AAA) [35,36]. The histopathology of aortic aneurysms is
dominated by a transmural degenerative process charac-
terized by medial atrophy and a gradual thinning and
weakening of the vessel wall [37]. Medial SMC density is
significantly decreased in AAA compared to normal aorta,
and SMC apoptosis contributes to medial degeneration
[38]. Therefore, if the smoking-related association in the
common carotid is similar to that in the abdominal aorta
(both are elastic-type arteries), the thinning carotid echo-
lucent layer found in our study may be attributed to the
medial atrophy. Third, the specific fibrogenic effect of
smoking may not only cause intimal thickening, but also
cause inflammation and density change of the media, ren-
dering it isoechoic with the intima and adventitia [39,40],
and thus an apparent thinner echolucent layer in ultra-
sonic image. This pathological change could help explain
why cigarette smoking was associated with greater disten-
sibility in spite of more severe and echogenic lesions in
another study [14].
The use of IMT progression over time as the sole outcome
(without including baseline IMT) in an epidemiological
study may result in spurious conclusions if not interpreted
properly. In the current study, after controlling for smok-
ing pack-years, the progression rate of IMT for current and
former smokers did not differ among both men and
women (see Table 4), which is consistent with other stud-
ies [41]. Nevertheless, it is inappropriate to infer that the
atherogenic effect of smoking is irreversible [41]. Rather,
our data suggest that the adverse effects of smoking are
partly reversible among former smokers. In comparison
with current smokers with similar pack-year exposure,
former smokers manifested lesser extent of intimal thick-
ening among both men and women. Particularly, the
echolucent-layer-thinning in association with smoking
was lessened among the subgroup of former female smok-
ers.
However, former smokers still manifest elevated athero-
sclerotic risk in comparison with never smokers. Prior
reports from population-based epidemiologic studies
examining relations between smoking cessation and
carotid atherosclerosis support our observation. Time-
since-quitting was related to the atherosclerotic score [42].
In the Atherosclerosis Risk in Community (ARIC) study,
former smokers display a large risk reduction in the first
two to three years after quitting but maintain a modest
elevated CAD risk for many years compared with that
among never smokers [41]. This biphasic decrease in car-
diovascular risk following smoking cessation indicates
that some adverse effects of smoking may be cumulative
and irreversible [41]. In the current study, the average time
since cessation among former smokers was 14 years
(range 0–40 yr). The relatively small samples of former
smoker (n = 117) limited the power to test the change of
IMT and its components as a function of time since cessa-
tion.
There are at least two limitations in this study. First, only
participants with IMT measurement 0.7 mm or greater
were included; the participants who fulfilled this criterion
may potentially possess higher levels of other risk factors
relative to those not included (as shown in Table 1). Thus
the results may not be generalized to the general popula-
tion. Second, the relatively short follow-up period (3
years) and the small sample size (n = 413) may have lim-
ited the power for detecting correlations between smoking
and carotid morphological changes. However, these two
limitations were at least partially compensated by the pre-
cision of the IMT measurement in this study [19].
Conclusion
This study examined carotid arterial morphological asso-
ciations (thickness of arterial wall and components)
detected by ultrasonography with cigarette smoking and
smoking cessation. The evidence provided may help moti-
vate early modification of the smoking habit and thus
delay or reverse the disease process [43]. Furthermore,
smoking-related carotid arterial morphological associa-
tions appeared to differ by sex; women may be more sus-
ceptible to arterial damage caused by cigarette smoking.
This is evidenced by simultaneous thickening of echo-
genic layer and thinning of echolucent layer among
female current smokers. Overall IMT alone may not be a
valid measure for detecting smoking-induced atheroscle-
rosis, especially among women. However, the results need
to be verified by larger longitudinal epidemiologic studies
using ultrasonography.BMC Cardiovascular Disorders 2006, 6:42 http://www.biomedcentral.com/1471-2261/6/42
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